Clinical Trials List
2026-01-02 - 2030-01-31
Phase II
Not yet recruiting6
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ko-Wei Chang 無
- 黃建達 無
- 胡漢忠 無
- 羅君禹 無
- 謝孟亨 無
- 吳振德 無
- 張博瑞 無
- Shu-Min Lin 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 黃維俊 無
- Chih-Yen Tu 無
- Wen-Chien Cheng 無
- 廖偉志 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 張晃智 無
- 陳友木 無
- Chia-Cheng Tseng 無
- 林孟志 無
- 蔡孟耘 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ming-Ju Tsai 無
- Hung-Ling Huang 無
- 鄭至宏 無
- jong rung Tsai 無
- Inn-Wen Chong 無
- 陳家閔 無
- 張旭良 無
- 鄭孟軒 無
- 莊政皓 無
- Wei-An Chang 無
- 李岱晃 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
165 participants
